These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2486540)

  • 1. Therapeutic implications of lipid-lowering agents in the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP; Schmitz PG
    Am J Med; 1989 Nov; 87(5N):21N-24N. PubMed ID: 2486540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia and progressive renal disease.
    Keane WF; Mulcahy WS; Kasiske BL; Kim Y; O'Donnell MP
    Kidney Int Suppl; 1991 Apr; 31():S41-8. PubMed ID: 2046270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lipids on glomerular injury and progression of renal disease.
    Keane WF
    Verh K Acad Geneeskd Belg; 1994; 56(2):91-104. PubMed ID: 8048270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids in progression of renal disease.
    Oda H; Keane WF
    Kidney Int Suppl; 1997 Nov; 62():S36-8. PubMed ID: 9350676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of antilipidemic therapies in chronic renal allograft failure.
    Wanner C; Bartens W; Galle J
    Kidney Int Suppl; 1995 Dec; 52():S60-2. PubMed ID: 8587286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is hyperlipidemia a factor in the progression of renal failure?].
    Geiger H
    Z Kardiol; 1993; 82 Suppl 4():35-8. PubMed ID: 8147060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of chronic renal disease.
    Klahr S
    Nutrition; 1990; 6(3):207-12. PubMed ID: 2135999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose and lipid control as risk factors in the progression of renal damage in type 2 diabetes.
    Nosadini R; Tonolo G
    J Nephrol; 2003; 16 Suppl 7():S42-7. PubMed ID: 14733300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonimmunologic mechanisms of glomerular injury.
    Olson JL; Heptinstall RH
    Lab Invest; 1988 Nov; 59(5):564-78. PubMed ID: 3054312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular structures and lipids in progressive renal disease.
    Moorhead JF; Wheeler DC; Varghese Z
    Am J Med; 1989 Nov; 87(5N):12N-20N. PubMed ID: 2486539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids and progressive renal failure.
    Keane WF
    Wien Klin Wochenschr; 1996; 108(14):420-4. PubMed ID: 8784983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of progression of glomerular sclerosis in chronic renal diseases in man].
    Garini G; Allegri L; Arisi L
    Ann Ital Med Int; 1989; 4(3):184-94. PubMed ID: 2702030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
    Chowdhury TA; Hopkins D; Dodson PM; Vafidis GC
    Eye (Lond); 2002 Nov; 16(6):689-93. PubMed ID: 12439660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and progressive kidney disease.
    Moorhead JF
    Kidney Int Suppl; 1991 Apr; 31():S35-40. PubMed ID: 2046269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.